Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Argyriou

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2025
Try before you buy: Empirical comparison of base editing approachesCatherine Argyriou, Aaron Nagiel
Translational Science of Rare Diseases|November 21, 2017
Peroxisome biogenesis disordersCatherine Argyriou, Maria Daniela D'Agostino, Nancy Braverman
Genetics in Medicine Open|June 16, 2025
Estimation of <i>PEX1</i>-mediated Zellweger spectrum disorder births and population prevalence by population genetics modelingKaren E Malone, Catherine Argyriou, Evelyn Zavacky, et al.
Plos One|November 21, 2012
An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of agingDantong Wang, Ying Wang, Catherine Argyriou, et al.
Journal of Lipid Research|March 9, 2025
Spatial characterization of RPE structure and lipids in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorderSamy Omri, Catherine Argyriou, Rachel S Pryce, et al.
Ophthalmology|August 4, 2023
Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature ReviewChristine Yergeau, Razek G Coussa, Fares Antaki, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Clinically relevant AAV8- <i>PEX1</i> gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorderSamy Omri, Erminia Di Pietro, Devin S McDougald, et al.
Experimental Eye Research|June 30, 2019
A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild Zellweger Spectrum DisorderCatherine Argyriou, Anna Polosa, Bruno Cecyre, et al.
Journal of Cellular Biochemistry|October 27, 2018
Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoidsGillian E MacLean, Catherine Argyriou, Erminia Di Pietro, et al.
Neurogenetics|February 2, 2022
Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case seriesAnthony Cheung, Catherine Argyriou, Christine Yergeau, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2025
Try before you buy: Empirical comparison of base editing approachesCatherine Argyriou, Aaron Nagiel
Translational Science of Rare Diseases|November 21, 2017
Peroxisome biogenesis disordersCatherine Argyriou, Maria Daniela D'Agostino, Nancy Braverman
Genetics in Medicine Open|June 16, 2025
Estimation of <i>PEX1</i>-mediated Zellweger spectrum disorder births and population prevalence by population genetics modelingKaren E Malone, Catherine Argyriou, Evelyn Zavacky, et al.
Plos One|November 21, 2012
An enhanced immune response of Mclk1⁺/⁻ mutant mice is associated with partial protection from fibrosis, cancer and the development of biomarkers of agingDantong Wang, Ying Wang, Catherine Argyriou, et al.
Journal of Lipid Research|March 9, 2025
Spatial characterization of RPE structure and lipids in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorderSamy Omri, Catherine Argyriou, Rachel S Pryce, et al.
Ophthalmology|August 4, 2023
Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature ReviewChristine Yergeau, Razek G Coussa, Fares Antaki, et al.
Biorxiv : the Preprint Server for Biology|May 25, 2026
Clinically relevant AAV8- <i>PEX1</i> gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorderSamy Omri, Erminia Di Pietro, Devin S McDougald, et al.
Experimental Eye Research|June 30, 2019
A longitudinal study of retinopathy in the PEX1-Gly844Asp mouse model for mild Zellweger Spectrum DisorderCatherine Argyriou, Anna Polosa, Bruno Cecyre, et al.
Journal of Cellular Biochemistry|October 27, 2018
Zellweger spectrum disorder patient-derived fibroblasts with the PEX1-Gly843Asp allele recover peroxisome functions in response to flavonoidsGillian E MacLean, Catherine Argyriou, Erminia Di Pietro, et al.
Neurogenetics|February 2, 2022
Clinical, neuroradiological, and molecular characterization of patients with atypical Zellweger spectrum disorder caused by PEX16 mutations: a case seriesAnthony Cheung, Catherine Argyriou, Christine Yergeau, et al.
Pageof 2